PRevention of Macular EDema After Cataract Surgery
Phase of Trial: Phase III
Latest Information Update: 02 Nov 2017
Price : $35 *
At a glance
- Drugs Bevacizumab (Primary) ; Bromfenac (Primary) ; Dexamethasone (Primary) ; Triamcinolone (Primary)
- Indications Diabetic macular oedema; Retinal oedema
- Focus Therapeutic Use
- Acronyms PREMED
- 31 Aug 2018 Biomarkers information updated
- 13 Apr 2017 Status changed from recruiting to completed.
- 06 Apr 2017 The trial has been completed in Germany, according to European Clinical Trials Database (End date: 13 Jan 2017).